Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 16:10:874.
doi: 10.3389/fonc.2020.00874. eCollection 2020.

Immunomodulation of NK Cells by Ionizing Radiation

Affiliations
Review

Immunomodulation of NK Cells by Ionizing Radiation

Jiarui Chen et al. Front Oncol. .

Abstract

Natural killer (NK) cells play a critical role in the antitumor immunity. Ionizing radiation (IR) has a pronounced effect on modifying NK cell biology, while the molecular mechanisms remain elusive. In this review, we briefly introduce the anti-tumor activity of NK cells and summarize the impact of IR on NK cells both directly and indirectly. On one hand, low-dose ionizing radiation (LDIR) activates NK functions while high-dose ionizing radiation (HDIR) is likely to partially impair NK functions, which can be reversed by interleukin (IL)-2 pretreatment. On the other hand, NK functions may be adjusted by other immune cells and the alternated malignant cell immunogenicity under the settings of IR. Various immune cells, such as the tumor-associated macrophage (TAM), dendritic cell (DC), regulatory T cell (Treg), myeloid-derived suppressor cell (MDSC), and tumor exhibited ligands, such as the natural killer group 2 member D ligand (NKG2DL), natural cytotoxicity receptors (NCR) ligand, TNF-related apoptosis-inducing ligand-receptor (TRAIL-R), and FAS, have been involved in this process. Better understanding the molecular basis is a promising way in which to augment NK-cell-based antitumor immunity in combination with IR.

Keywords: NK cell; immune response; immunotherapy; ionizing radiation; tumor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The impact of IR on NK cell. IR has a pronounced effect on modifying NK cell biology both directly and indirectly. On the one hand, IR induces the secretion of IFN-γ, TNF-α, perforin, and granzyme B of NK cells possibly through the p38-MAPK, ATM, and NF-κB pathway without alteration of activating receptors. On the other hand, IR programs the differentiation of classical activated macrophage (M1), which releases immunostimulatory IL-12 or IL-18 and triggers NK cytotoxicity. DC exposed to LDIR produces enhanced IL-2 and IFN-γ which promote NK functions while DC exposed to HDIR secretes less IL-12. IR also leads to the recruitment and activation of pro-tumor TAN phenotype (N2), alternatively activated macrophage (M2), Treg and MDSC which secrete TGF-β and impair NK activity. Finally, tumor expressed ligands, such as NKG2DL, TRAIL-R, and FAS, are upregulated during IR, enhancing the recognition of malignant cells by NK cells. However, PD-L1, classical HLA class I, sNKG2DL are also upregulated during IR, impairing the immunogenicity of tumor cells and NK cell recognition. See the main text for details. IR, ionizing radiation; NK cell, natural killer cell; IFN-γ, interferon-γ; TNF-α, tumor necrosis factor-α; MAPK, mitogen-activated protein kinase; ATM, ataxia telangiectasia mutated; NF-κB, nuclear factor kappa B; IL, interleukin; DC, dendritic cell; LDIR, low-dose ionizing radiation; HDIR, high-dose ionizing radiation; TAN, tumor-associated neutrophil; Treg, regulatory T cell; MDSC, myeloid-derived suppressor cell; TGF-β, transforming growth factor-β; NKG2DL, natural killer group 2 member D ligand; TRAIL-R, TNF-related apoptosis-inducing ligand-receptor; PD-L1, programmed death ligand 1; HLA, human leukocyte antigen; sNKG2DL, soluble natural killer group 2 member D ligand.

Similar articles

Cited by

References

    1. Artis D, Spits H. The biology of innate lymphoid cells. Nature. (2015) 517:293–301. 10.1038/nature14189 - DOI - PubMed
    1. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science. (2011) 331:44–9. 10.1126/science.1198687 - DOI - PMC - PubMed
    1. Stabile H, Fionda C, Gismondi A, Santoni A. Role of distinct natural killer cell subsets in anticancer response. Front Immunol. (2017) 8:293. 10.3389/fimmu.2017.00293 - DOI - PMC - PubMed
    1. Du Y, Wei Y. Therapeutic potential of natural killer cells in gastric cancer. Front Immunol. (2019) 9:3095. 10.3389/fimmu.2018.03095 - DOI - PMC - PubMed
    1. Leong JW, Wagner JA, Ireland AR, Fehniger TA. Transcriptional and post-transcriptional regulation of NK cell development and function. Clin Immunol. (2017) 177:60–9. 10.1016/j.clim.2016.03.003 - DOI - PMC - PubMed